• Alphatec Holdings lowered its 2026 revenue outlook to $862 million, representing 13% growth.
• Adjusted EBITDA guidance remains $137 million, up 47%.
• Free cash flow is projected at $10 million.
• The revenue forecast includes surgical revenue of $789 million and EOS revenue of $73 million.
• Surgical growth assumptions include high-teens case volume growth and a low-single-digit decline in revenue per case.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alphatec Holdings Inc. published the original content used to generate this news brief on October 29, 2026, and is solely responsible for the information contained therein.